Central Trust Company’s BeOne Medicines Ltd ONC Stock Holding History

Central Trust Company’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19K	Buy	+4	New	+$1.29K	﹤0.01%	1404
2025 Q4	–	Hold	0	–	–	–	1528
2024 Q4	–	Sell	-1	Closed	-$144	–	1519
2024 Q3	$144	Buy	+1	New	+$180	﹤0.01%	1409
2020 Q2	–	Sell	-40	Closed	-$5K	–	1172
2020 Q1	$5K	Hold	40	–	–	﹤0.01%	991
2019 Q4	$7K	Hold	40	–	–	﹤0.01%	1007
2019 Q3	$5K	Hold	40	–	–	﹤0.01%	1048
2019 Q2	$5K	Buy	+40	New	+$5.08K	﹤0.01%	1040

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Central Trust Company's ONC Position: Q1 2026 in Review

Central Trust Company opened a new position in BeOne Medicines Ltd (ONC) in Q1 2026: 4 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #1404 among its holdings. This is a return to the name: Central Trust Company previously reported a position in ONC as recently as Q3 2024.

Central Trust Company first reported a position in ONC in Q2 2019 and has held it in 6 quarters since. The position peaked at $7K in Q4 2019. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Central Trust Company held 4 shares of BeOne Medicines Ltd worth $1.19K as of Q1 2026.
BeOne Medicines Ltd was a new Central Trust Company position in Q1 2026.
BeOne Medicines Ltd made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1404 holding.
Central Trust Company first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 6 quarters since.
Central Trust Company's BeOne Medicines Ltd position peaked at $7K in Q4 2019.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.